本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

罗氏控股

45.15
+0.47501.06%
成交量:91.44万
成交额:4,104.45万
市值:2,876.19亿
市盈率:29.11
高:45.15
开:44.54
低:44.50
收:44.67
52周最高:45.94
52周最低:34.10
股本:63.71亿
流通股本:63.71亿
量比:0.76
换手率:0.01%
股息:1.53
股息率:3.39%
每股收益(TTM):1.55
每股收益(LYR):2.14
净资产收益率:31.32%
总资产收益率:13.30%
市净率:7.95
市盈率(LYR):21.13

数据加载中...

公司资料

公司名字:
罗氏控股
交易所:
OTCQX
成立时间:
1896
员工人数:
103249
公司地址:
Grenzacherstrasse 124,Basel,Basel-Stadt,Switzerland
邮编:
4070
传真:
41 61 691 00 14
简介:
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Further, the company discovers, develops, and delivers gene therapies. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.